FVII or FVIIa variants

Details for Australian Patent Application No. 2010201201 (hide)

Owner Bayer HealthCare LLC

Inventors Andersen, Kim Vilbour; Glazer, Steven; Haaning, Jesper Mortensen; Ropke, Mads

Agent Spruson & Ferguson

Pub. Number AU-A-2010201201

Parent 2004221761

Filing date 25 March 2010

Wipo publication date 15 April 2010

International Classifications

C12N 9/64 (2006.01) Enzymes, e.g. ligases (6.) - derived from animal tissue, e.g. rennin

A61K 38/48 (2006.01) Medicinal preparations containing peptides

C12N 15/57 (2006.01) Mutation or genetic engineering - acting on peptide bonds (3.4)

Event Publications

15 April 2010 Application Open to Public Inspection

  Published as AU-A-2010201201

15 April 2010 Complete Application Filed

20 October 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010201202-Suture management port

2010201200-Patient selectable joint arthroplasty devices and surgical tools facilitating increased accuracy, speed and simplicity in performing total and partial joint arthroplasty